Phillips-Medisize (Molex / Koch Industries)

What they make

1 input Phillips-Medisize (Molex / Koch Industries) supplies

Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.

Intelligence

What's known

Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.

• Did you know2024

  Koch Industries' industrial portfolio, through its subsidiaries, spans multiple supply chains simultaneously: Flint Hills Resources (oil refineries in Corpus Christi, TX and Pine Bend, MN) produces gasoline and diesel; Koch Fertilizer produces urea ammonium nitrate and anhydrous ammonia for agriculture; Georgia-Pacific produces tissue paper, paper bags, and building products from timber; Invista produces Lycra spandex fiber; and Phillips-Medisize (via Molex) produces injection-molded polymer drug delivery device housings for pharmaceutical companies. The same privately held Koch Industries is simultaneously a major input to the petroleum industry, agricultural production, tissue/paper supply chains, synthetic fiber manufacturing, and pharmaceutical device manufacturing — all without a publicly traded share or public financial disclosure. A financial shock, regulatory action, or geopolitical sanction targeting Koch Industries as an entity would simultaneously affect fuel supply, crop fertilization, tissue paper supply, athletic apparel materials, and pharmaceutical device component availability.

  Koch Industries, Inc. ↗

• Concentration2024

  Phillips-Medisize is a large-scale contract manufacturer for the auto-injector pen devices used to administer biologics — adalimumab (Humira/Hadlima/Cyltezo biosimilars), etanercept, trastuzumab (Herceptin biosimilars), insulin analogs, and epinephrine (EpiPen-type emergency allergy kits). Auto-injectors are a rapidly growing drug delivery modality as patents expire on biologic drugs and biosimilars require the same device platforms as their branded predecessors. The polymer auto-injector supply chain runs through a small set of contract manufacturers (Phillips-Medisize, Haselmeier, Ypsomed, Owen Mumford) and their injection molding suppliers. For patients with severe allergies who depend on epinephrine auto-injectors (EpiPen, Auvi-Q) for anaphylaxis emergencies, the device housing is as essential as the epinephrine — a device shortage is an emergency equivalent. Mylan's 2016 EpiPen pricing scandal, which drew widespread attention to the epinephrine auto-injector supply chain, highlighted how the device component supply chain is opaque even to regulators examining drug pricing.

  Phillips-Medisize (Koch / Molex) ↗

• Origin2016

  Koch Industries — the private conglomerate run by Charles Koch, best known for oil refining (Flint Hills Resources), petrochemicals, fertilizers (Koch Fertilizer), paper products (Georgia-Pacific, maker of Brawny, Quilted Northern, Dixie cups), and Invista (Lycra spandex) — owns a major medical device contract manufacturing company. In 2016, Koch's electronics subsidiary Molex (acquired by Koch in 2013) acquired Phillips-Medisize for approximately $1.7 billion, making Koch Industries a supplier of the injection-molded polymer components inside asthma inhalers, auto-injector pens for biologics, and diagnostic medical devices. Most people who associate Koch Industries with oil pipelines, libertarian political donations, and paper towels have no idea that the same conglomerate manufactures the plastic housings for pharmaceutical drug delivery devices. This is exactly the kind of industrial surprise the supply chain radar was built to surface.

  BusinessWire / Koch Industries ↗